Andere Sprachen Immuron Limited

Aktien

Markt geschlossen - Australian S.E. Andere Börsenplätze 06:29:33 31.05.2024			% 5 Tage	% 1. Jan.
0,094 ^AUD	-3,09 %		-.--%	+22,08 %

31.05.	Immuron Limited kündigt Rücktritt von Roger Aston als Non-Executive Director an	CI
03.05.	Immuron Limited gibt den Rücktritt von Stephen Anastasiou als Non-Executive Director bekannt	CI

Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	31.05.
Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	03.05.
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10.04.
Sector Update: Health Care Stocks Gain Late Afternoon	07.03.
Sector Update: Health Care	07.03.
Top Midday Gainers	07.03.
Top Premarket Gainers	07.03.
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07.03.
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	07.03.
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28.02.
Immuron Posts Record Travelan Sales in Fiscal H1	16.01.
Immuron Limited Clinical Trials Update	22.12.
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	04.12.
Immuron Limited Announces Travelan® Clinical Study Cohort 2 Commences	18.10.23
Immuron Reports Big Jump in Fiscal Q1 Travelan Sales	11.10.23
Immuron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30.08.23
Immuron Limited Receives TGA GMP Clearance	09.08.23
Immuron Secures Clearance for Packaging of Immunotherapy Product; Shares Surge 27%	09.08.23
Immuron Says First Patients Enrolled in Travelan Trial	25.07.23
Immuron Limited Announces First Patients Enrolled in Travelan® Clinical Study	25.07.23

Keine Ergebnisse zu dieser Suche